27707823|t|Toxoplasma gondii seroprevalence in the Portuguese population: comparison of three cross-sectional studies spanning three decades
27707823|a|Toxoplasma gondii is an obligate intracellular protozoan infecting up to one-third of the world's population, constituting a life threat if transmitted from mother to child during pregnancy. In Portugal, there is a lack of knowledge of the current epidemiological situation, as the unique toxoplasmosis National Serological Survey was performed in 1979/1980. We studied the seroprevalence trends in the Portuguese general population over the past 3 decades, by assessing chronological spread cross-sectional studies, with special focus on women of childbearing age, by age group, region and gender. The T. gondii overall seroprevalence decreased from 47% in 1979/1980 to 22% (95% CI 20% to 24%) in 2013. Generally, we observed that the prevalence of T. gondii IgG increased significantly with age and it decreased over time, both in the general population and in the childbearing women (18% prevalence in 2013). The scenario observed for the latter indicates that more than 80% of childbearing women are susceptible to primary infection yielding a risk of congenital toxoplasmosis and respective sequelae. Since there is no vaccine to prevent human toxoplasmosis, the improvement of primary prevention constitutes a major tool to avoid infection in such susceptible groups.
27707823	0	17	Toxoplasma gondii	T204	UMLS:C0040557
27707823	18	32	seroprevalence	T062	UMLS:C0600367
27707823	40	61	Portuguese population	T098	UMLS:C0032730
27707823	83	106	cross-sectional studies	T062	UMLS:C0010362
27707823	130	147	Toxoplasma gondii	T204	UMLS:C0040557
27707823	163	176	intracellular	T082	UMLS:C0178719
27707823	177	186	protozoan	T204	UMLS:C0033739
27707823	220	238	world's population	T098	UMLS:C2700280
27707823	255	266	life threat	T033	UMLS:C2826244
27707823	310	319	pregnancy	T038	UMLS:C0032961
27707823	324	332	Portugal	T082	UMLS:C0032729
27707823	419	432	toxoplasmosis	T038	UMLS:C0040558
27707823	504	518	seroprevalence	T062	UMLS:C0600367
27707823	533	562	Portuguese general population	T098	UMLS:C0032730
27707823	622	645	cross-sectional studies	T062	UMLS:C0010362
27707823	669	674	women	T098	UMLS:C0043210
27707823	678	690	childbearing	T038	UMLS:C0031845
27707823	710	716	region	T082	UMLS:C0017446
27707823	733	742	T. gondii	T204	UMLS:C0040557
27707823	751	765	seroprevalence	T062	UMLS:C0600367
27707823	880	889	T. gondii	T204	UMLS:C0040557
27707823	890	893	IgG	T103	UMLS:C0020852
27707823	997	1009	childbearing	T038	UMLS:C0031845
27707823	1010	1015	women	T098	UMLS:C0043210
27707823	1111	1123	childbearing	T038	UMLS:C0031845
27707823	1124	1129	women	T098	UMLS:C0043210
27707823	1157	1166	infection	T038	UMLS:C3714514
27707823	1186	1210	congenital toxoplasmosis	T038	UMLS:C0040560
27707823	1226	1234	sequelae	T038	UMLS:C0243088
27707823	1251	1253	no	T033	UMLS:C1513916
27707823	1254	1261	vaccine	T103	UMLS:C0042210
27707823	1273	1278	human	T204	UMLS:C0086418
27707823	1279	1292	toxoplasmosis	T038	UMLS:C0040558
27707823	1313	1331	primary prevention	T058	UMLS:C0033144
27707823	1366	1375	infection	T038	UMLS:C3714514
27707823	1396	1402	groups	T098	UMLS:C1257890